# Antidepressants and Bone Mineral Density

> **NCT02179268** · PHASE3 · COMPLETED · sponsor: **Guiyang Medical University** · enrollment: 203 (actual)

## Conditions studied

- Bone Mineral Density Quantitative Trait Locus 7

## Interventions

- **DRUG:** sertraline
- **DRUG:** citalopram
- **DRUG:** venlafaxine
- **DRUG:** reboxetine
- **BEHAVIORAL:** control

## Key facts

- **NCT ID:** NCT02179268
- **Lead sponsor:** Guiyang Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2014-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02179268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02179268, "Antidepressants and Bone Mineral Density". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02179268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*